ReviewCancer management and research2020

Optimal Care for Patients with Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer: A Review on the Role and Utility of ALK Inhibitors.

Abhay Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.